Tape strips from early‐onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin
暂无分享,去创建一个
A. Paller | Ning Zhang | J. Krueger | E. Guttman‐Yassky | Y. Renert-Yuval | A. Pavel | Jianni Wu | E. Del Duca | A. Diaz | R. Lefferdink | T. Canter | S. Rangel | M. Fang | E. Guttman-Yassky
[1] E. Guttman‐Yassky,et al. Efficacy of biologics in atopic dermatitis , 2020, Expert opinion on biological therapy.
[2] A. Paller,et al. Product of Investigator Global Assessment and body surface area (IGAxBSA): a practice-friendly alternative to the Eczema Area and Severity Index (EASI) to assess atopic dermatitis severity in children. , 2020, Journal of the American Academy of Dermatology.
[3] D. Margolis,et al. Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: a cohort study. , 2019, Journal of the American Academy of Dermatology.
[4] John D. Davis,et al. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis , 2019, JAMA dermatology.
[5] D. Leung,et al. Side-by-side Comparison of Skin Biopsies and Skin Tape Stripping Highlights Abnormal Stratum Corneum in Atopic Dermatitis. , 2019, The Journal of investigative dermatology.
[6] A. Paller,et al. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis. , 2019, JAMA dermatology.
[7] R. Bissonnette,et al. Major differences in expression of inflammatory pathways in skin from different body sites of healthy individuals. , 2019, The Journal of investigative dermatology.
[8] A. Paller,et al. The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease. , 2019, Journal of the American Academy of Dermatology.
[9] Ning Zhang,et al. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis. , 2019, The Journal of allergy and clinical immunology.
[10] Y. Ohya,et al. Effect of filaggrin loss-of-function mutations on atopic dermatitis in young age: a longitudinal birth cohort study , 2019, Journal of Human Genetics.
[11] Hyun Je Kim,et al. Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patients. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[12] R. Cole,et al. The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype , 2019, Science Translational Medicine.
[13] Ning Zhang,et al. Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[14] S. Kežić,et al. Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell‐related immunity and angiogenesis , 2018, The British journal of dermatology.
[15] Hyun Je Kim,et al. Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood , 2019 .
[16] J. Krueger,et al. Increased cardiovascular and atherosclerosis markers in blood of older atopic dermatitis patients. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[17] J. Krueger,et al. Atopic dermatitis endotypes and implications for targeted therapeutics. , 2019, The Journal of allergy and clinical immunology.
[18] J. Silverberg,et al. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis , 2019, The Journal of allergy and clinical immunology.
[19] Ning Zhang,et al. Early‐onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22‐centered inflammation and lipid alterations , 2018, The Journal of allergy and clinical immunology.
[20] J. Wenzel,et al. Detection of IL-36γ through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema , 2018, The Journal of allergy and clinical immunology.
[21] M. Seibold,et al. Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2–high atopic dermatitis disease endotype , 2018, The Journal of allergy and clinical immunology.
[22] M. Seibold,et al. Lipid abnormalities in atopic skin are driven by type 2 cytokines. , 2018, JCI insight.
[23] M. Seibold,et al. Olfactory Receptors Expression in the Skin of Atopic Dermatitis Patients , 2018 .
[24] L. Brkljacic,et al. Quantification of free fatty acids in human stratum corneum using tandem mass spectrometry and surrogate analyte approach. , 2018, Biomedical chromatography : BMC.
[25] T. Agner,et al. Measurements of AMPs in stratum corneum of atopic dermatitis and healthy skin–tape stripping technique , 2018, Scientific Reports.
[26] D. Leung,et al. Significance of Skin Barrier Dysfunction in Atopic Dermatitis , 2018, Allergy, asthma & immunology research.
[27] M. Sears,et al. Predicting the atopic march: Results from the Canadian Healthy Infant Longitudinal Development Study , 2017, The Journal of allergy and clinical immunology.
[28] David M. Evans,et al. Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts , 2017, Pediatrics.
[29] S. Kežić,et al. Stratum corneum analysis provide a minimal invasive tool to study immune response and skin barrier in atopic dermatitis children , 2018 .
[30] D. Leung,et al. Immunologic, microbial, and epithelial interactions in atopic dermatitis. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[31] A. Paller,et al. Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. , 2016, The Journal of allergy and clinical immunology.
[32] M. Frings-Dresen,et al. Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy , 2016, International Archives of Allergy and Immunology.
[33] R. Moritz,et al. Quantitative Proteomic Analysis of Stratum Corneum Dysfunction in Adult Chronic Atopic Dermatitis. , 2016, The Journal of investigative dermatology.
[34] M. Lebwohl,et al. Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism. , 2016, The Journal of allergy and clinical immunology.
[35] S. Kežić,et al. Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis , 2015, The Journal of allergy and clinical immunology.
[36] Mayte Suárez-Fariñas,et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. , 2015, The Journal of allergy and clinical immunology.
[37] K. Eyerich,et al. Th22 cells in allergic disease , 2015, Allergo Journal International.
[38] T. Litman,et al. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. , 2015, The Journal of allergy and clinical immunology.
[39] Y. Tokura,et al. Proteome analysis of stratum corneum from atopic dermatitis patients by hybrid quadrupole-orbitrap mass spectrometer. , 2014, The Journal of allergy and clinical immunology.
[40] M. Suárez-Fariñas,et al. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. , 2014, The Journal of allergy and clinical immunology.
[41] J. Bouwstra,et al. TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. , 2014, The Journal of investigative dermatology.
[42] Jun Zhong,et al. TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling , 2014, Database J. Biol. Databases Curation.
[43] T. Agner,et al. Human β‐defensin‐2 as a marker for disease severity and skin barrier properties in atopic dermatitis , 2013, The British journal of dermatology.
[44] M. Suárez-Fariñas,et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.
[45] D. Leung,et al. IL-25 Enhances HSV-1 Replication by Inhibiting Filaggrin Expression, and Acts Synergistically with TH2 Cytokines to Enhance HSV-1 Replication , 2013, The Journal of investigative dermatology.
[46] R. Tamagawa‐Mineoka,et al. Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis , 2013, Clinical and experimental immunology.
[47] T. Hankemeier,et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients[S] , 2012, Journal of Lipid Research.
[48] M. Suárez-Fariñas,et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. , 2012, The Journal of allergy and clinical immunology.
[49] I. Dekio,et al. Interleukin-8 Content in the Stratum Corneum as an Indicator of the Severity of Inflammation in the Lesions of Atopic Dermatitis , 2012, International Archives of Allergy and Immunology.
[50] G. Ogg,et al. Interleukin‐22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes , 2011, The British journal of dermatology.
[51] S. Kežić,et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity , 2011, Allergy.
[52] R. Neubert,et al. Distinct barrier integrity phenotypes in filaggrin‐related atopic eczema following sequential tape stripping and lipid profiling , 2011, Experimental dermatology.
[53] A. Bowcock,et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. , 2011, The Journal of allergy and clinical immunology.
[54] Carolyn J. Broccardo,et al. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. , 2011, The Journal of allergy and clinical immunology.
[55] I. Dekio,et al. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis , 2010, Allergy.
[56] Mayte Suárez-Fariñas,et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. , 2009, The Journal of allergy and clinical immunology.
[57] M. Strand,et al. Peeling off the layers: skin taping and a novel proteomics approach to study atopic dermatitis. , 2009, The Journal of allergy and clinical immunology.
[58] H. Spits,et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells , 2009, Nature Immunology.
[59] R. Voegeli,et al. Increased stratum corneum serine protease activity in acute eczematous atopic skin , 2009, The British journal of dermatology.
[60] K. Barnes,et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. , 2009, The Journal of allergy and clinical immunology.
[61] Z. Ikezawa,et al. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. , 2009, Journal of dermatological science.
[62] Yong‐jun Liu,et al. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. , 2007, The Journal of allergy and clinical immunology.
[63] D. Strachan,et al. Natural history of atopic dermatitis and its relationship to serum total immunoglobulin E in a population‐based birth cohort study , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[64] T. Bieber,et al. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. , 1996, The Journal of investigative dermatology.